Mahamadou Camara

Articles

Article: NUCLEIC ACIDS RESEARCH. 2025;53(D1):D1498-D1509
PharmFreq: a comprehensive atlas of ethnogeographic allelic variation in clinically important pharmacogenes
Tremmel R; Zhou Y; Camara MD; Laarif S; Eliasson E; Lauschke VM
Article: JOURNAL OF GENETICS AND GENOMICS. 2024;51(11):1228-1236
Population-scale variability of the human UDP-glycosyltransferase gene family
Gonzalez-Padilla D; Camara MD; Lauschke VM; Zhou Y
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2024;68(5):e01390-e01323
Population-specific variations in KCNH2 predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy
Camara MD; Zhou Y; Dara A; Tekete MM; de Sousa TN; Sissoko S; Dembele L; Ouologuem N; Togo AH; Alhousseini ML; Fofana B; Sagara I; Djimde AA; Gil PJ; Lauschke VM
Article: HUMAN GENOMICS. 2024;18(1):40
Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences
Camara MD; Zhou Y; De Sousa TN; Gil JP; Djimde AA; Lauschke VM

Review: ANNALS OF HUMAN GENETICS. 2025;89(5):384-397
Opportunities and Challenges of Population Pharmacogenomics
Zhou Y; Park Y; Camara MD; Lauschke VM
Review: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2022;18(1):39-59
An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria
Pernaute-Lau L; Camara M; de Sousa TN; Morris U; Ferreira MU; Gil JP